PayamNahidMD
Pulmonology • San Francisco, CACritical Care Medicine, Pleural Disease
Associate Professor, Medicine, UCSF School of Medicine
Are you Dr. Nahid?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1001 Potrero Ave
5k1
San Francisco, CA 94110Phone+1 415-206-8313Fax+1 415-695-1551
Summary
- Dr. Payam Nahid, MD is a pulmonologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with Zuckerberg San Francisco General Hospital and Trauma Center and UCSF Medical Center.
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
Scripps Clinic/Scripps Green HospitalResidency, Internal Medicine, 1998 - 2001
University of California (Irvine)Internship, Internal Medicine, 1997 - 1998
University of California, Irvine, School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1999 - 2026- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- C-reactive Protein-based Screening of People with Tuberculosis Symptoms: A Diagnostic Accuracy Study.Brigitta Derendinger, Tessa K Mochizuki, Danaida Marcelo, Deepa Shankar, Wilson Mangeni
American Journal of Respiratory and Critical Care Medicine. 2024-12-06 - Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.Ava Y Xu, Gustavo E Velásquez, Nan Zhang, Vincent K Chang, Patrick P J Phillips
American Journal of Respiratory and Critical Care Medicine. 2024-12-01 - 1 citationsDiagnostic accuracy of TB screening tests in a prospective multinational cohort: Chest-X-ray with computer-aided detection, Xpert TB host response, and C-reactive prot...Rebecca Crowder, Balamugesh Thangakunam, Alfred Andama, Devasahayam J Christopher, Victoria Dalay
Clinical Infectious Diseases. 2024-11-07
Press Mentions
UCSF Joins $200 Million Global Tuberculosis ConsortiumAugust 2nd, 2022- Study: Four-Month Regimen of Anti-TB Drugs Works Just as Well as Standard RegimenMay 24th, 2021
New TB Drug Regimen Controls Resistant Disease in 9 of 10 Cases: StudyMarch 4th, 2020- Join now to see all
Grant Support
- Interplay Of Strain And Ethnicity In The Immune Response To M. TuberculosisNational Heart, Lung, And Blood Institute2007–2011
